AEye Reports Third Quarter 2024 Results
Apollo shines in major in-vehicle driving test with NVIDIA
Plan to establish Apollo manufacturing line with LITEON in 2024
Quarterly Business Highlights
- Apollo met the NVIDIA DRIVE Hyperion specifications, paving way for platform integration
- Apollo samples shipped to OEMs; sets new long-distance performance standard of 1 kilometer
- Apollo manufacturing line planned with LITEON in 2024, quoting multiple OEMs
- New financial instruments extend cash runway; pave way to automotive mass production
Management Commentary
“During the quarter, we demonstrated that Apollo met the NVIDIA Hyperion specifications, which demand a challenging combination of high-resolution detection at very long distances. This major in-vehicle driving test is a significant achievement that further validates the strength of our technology and paves the way for deeper integration with the NVIDIA platform.
“We made significant progress with our partners over the quarter. ATI, our partner in
“Our ability to attract new investors to
Third Quarter 2024 Financial Highlights
-
Quarterly revenue of
$104 thousand , primarily from sales of inventory to non-automotive customers, meeting consensus estimates -
Cash burn of
$5.6 million , beating guidance of$5.9 million -
GAAP net loss was
$(8.7) million , or$(1.01) per share, based on 8.6 million weighted average common shares outstanding -
Non-GAAP net loss was
$(6.0) million , or$(0.70) per share, based on 8.6 million weighted average common shares outstanding, beating consensus estimates -
Cash, cash equivalents, and marketable securities were
$22.4 million as ofSeptember 30, 2024
“We believe our unique capital-light model is a key differentiator in the lidar market. Not only does it allow us to maintain a balance sheet with very little debt compared to some of our peers, it also gives us what we believe is the lowest cost structure in the industry. We expect this will lead to greater efficiencies as we can do more with less. We believe this is a powerful selling point to OEMs, as it enables us to offer a superior product at a competitive price point.
“We ended the quarter with
In
Conference Call and Webcast Details
The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.
Access is also available via:
Conference call: https://aeye.pub/48pgxWe
Webcast: https://aeye.pub/4e8yny0
About
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance.
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in
This press release includes non-GAAP financial measures, including:
- Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to registration statements and common stock purchase agreements, less change in fair value of convertible note and warrant liabilities, plus realized loss on instrument-specific credit risk, plus one-time termination benefits and other restructuring costs, plus non-routine write-down of inventory, plus impairment of right-of-use assets, less gain on termination of operating lease, net; and
- Adjusted EBITDA, defined as non-GAAP net loss plus depreciation and amortization expense, less interest income and other, less interest expense and other, plus provision for income tax expense.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about deeper integration of Apollo with the NVIDIA DRIVE Hyperion platform, the success of global OEM quoting activities, LITEON’s anticipated establishment of a manufacturing line in 2024, the potential liquidity available to
Readers are cautioned not to put undue reliance on forward-looking statements;
Consolidated Balance Sheets (In thousands) (Unaudited) |
|||||||
|
|
||||||
ASSETS | |||||||
Current Assets: | |||||||
Cash and cash equivalents |
$ |
5,851 |
|
$ |
16,932 |
|
|
Marketable securities |
|
16,584 |
|
|
19,591 |
|
|
Accounts receivable, net |
|
76 |
|
|
131 |
|
|
Inventories, net |
|
258 |
|
|
583 |
|
|
Prepaid and other current assets |
|
1,482 |
|
|
2,517 |
|
|
Total current assets |
|
24,251 |
|
|
39,754 |
|
|
Right-of-use assets |
|
703 |
|
|
11,226 |
|
|
Property and equipment, net |
|
630 |
|
|
281 |
|
|
Restricted cash |
|
— |
|
|
2,150 |
|
|
Other noncurrent assets |
|
784 |
|
|
906 |
|
|
Total assets |
$ |
26,368 |
|
$ |
54,317 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current Liabilities: | |||||||
Accounts payable |
$ |
3,717 |
|
$ |
3,442 |
|
|
Accrued expenses and other current liabilities |
|
6,960 |
|
|
6,585 |
|
|
Contract liabilities |
|
35 |
|
|
— |
|
|
Total current liabilities |
|
10,712 |
|
|
10,027 |
|
|
Operating lease liabilities, noncurrent |
|
537 |
|
|
14,858 |
|
|
Convertible note |
|
146 |
|
|
— |
|
|
Other noncurrent liabilities |
|
67 |
|
|
409 |
|
|
Total liabilities |
|
11,462 |
|
|
25,294 |
|
|
Stockholders’ Equity: | |||||||
Preferred stock |
|
— |
|
|
— |
|
|
Common stock |
|
1 |
|
|
1 |
|
|
Additional paid-in capital |
|
379,425 |
|
|
366,647 |
|
|
Accumulated other comprehensive income |
|
27 |
|
|
10 |
|
|
Accumulated deficit |
|
(364,547 |
) |
|
(337,635 |
) |
|
Total stockholders’ equity |
|
14,906 |
|
|
29,023 |
|
|
Total liabilities and stockholders’ equity |
$ |
26,368 |
|
$ |
54,317 |
|
|
Consolidated Statements of Operations (In thousands, except share amounts and per share data) (Unaudited) |
|||||||||||||||
Three months ended |
Nine months ended |
||||||||||||||
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Revenue: | |||||||||||||||
Prototype sales |
$ |
65 |
|
$ |
56 |
|
$ |
91 |
|
$ |
426 |
|
|||
Development contracts |
|
39 |
|
|
132 |
|
|
65 |
|
|
969 |
|
|||
Total revenue |
|
104 |
|
|
188 |
|
|
156 |
|
|
1,395 |
|
|||
Cost of revenue |
|
306 |
|
|
4,479 |
|
|
729 |
|
|
8,651 |
|
|||
Gross loss |
|
(202 |
) |
|
(4,291 |
) |
|
(573 |
) |
|
(7,256 |
) |
|||
Operating expenses: | |||||||||||||||
Research and development |
|
3,767 |
|
|
5,654 |
|
|
12,137 |
|
|
20,993 |
|
|||
Sales and marketing |
|
74 |
|
|
1,910 |
|
|
482 |
|
|
10,782 |
|
|||
General and administrative |
|
3,803 |
|
|
5,380 |
|
|
13,641 |
|
|
20,279 |
|
|||
Total operating expenses |
|
7,644 |
|
|
12,944 |
|
|
26,260 |
|
|
52,054 |
|
|||
Loss from operations |
|
(7,846 |
) |
|
(17,235 |
) |
|
(26,833 |
) |
|
(59,310 |
) |
|||
Other income (expense): | |||||||||||||||
Change in fair value of convertible note and warrant liabilities |
|
9 |
|
|
12 |
|
|
(4 |
) |
|
(914 |
) |
|||
Interest income and other |
|
233 |
|
|
354 |
|
|
656 |
|
|
932 |
|
|||
Interest expense and other |
|
(1,102 |
) |
|
(174 |
) |
|
(729 |
) |
|
(9 |
) |
|||
Total other income (expense), net |
|
(860 |
) |
|
192 |
|
|
(77 |
) |
|
9 |
|
|||
Loss before income tax expense |
|
(8,706 |
) |
|
(17,043 |
) |
|
(26,910 |
) |
|
(59,301 |
) |
|||
Provision for income tax expense |
|
— |
|
|
5 |
|
|
2 |
|
|
43 |
|
|||
Net loss |
$ |
(8,706 |
) |
$ |
(17,048 |
) |
$ |
(26,912 |
) |
$ |
(59,344 |
) |
|||
Per Share Data | |||||||||||||||
Net loss per common share (basic and diluted) |
$ |
(1.01 |
) |
$ |
(2.78 |
) |
$ |
(3.90 |
) |
$ |
(10.34 |
) |
|||
Weighted average common shares outstanding (basic and diluted) |
|
8,629,683 |
|
|
6,137,251 |
|
|
6,892,910 |
|
|
5,739,425 |
|
|||
Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
|||||||
Nine months ended |
|||||||
|
2024 |
|
|
2023 |
|
||
Cash flows from operating activities: | |||||||
Net loss |
$ |
(26,912 |
) |
$ |
(59,344 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization |
|
80 |
|
|
998 |
|
|
Loss (gain) on sale of property and equipment, net |
|
(12 |
) |
|
53 |
|
|
Noncash lease expense relating to operating lease right-of-use assets |
|
905 |
|
|
1,058 |
|
|
Gain on termination of operating lease, net |
|
(680 |
) |
|
— |
|
|
Common stock purchase agreement costs |
|
1,136 |
|
|
— |
|
|
Impairment of right-of-use assets |
|
— |
|
|
47 |
|
|
Inventory write-downs, net of scrapped inventory |
|
167 |
|
|
3,666 |
|
|
Change in fair value of convertible note and warrant liabilities |
|
4 |
|
|
914 |
|
|
Realized loss on instrument-specific credit risk |
|
— |
|
|
46 |
|
|
Stock-based compensation |
|
7,002 |
|
|
14,707 |
|
|
Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest |
|
(491 |
) |
|
33 |
|
|
Expected credit losses, net of write-offs |
|
35 |
|
|
— |
|
|
Changes in operating assets and liabilities: | |||||||
Accounts receivable, net |
|
20 |
|
|
379 |
|
|
Inventories, current and noncurrent, net |
|
157 |
|
|
(2,681 |
) |
|
Prepaid and other current assets |
|
1,035 |
|
|
1,672 |
|
|
Other noncurrent assets |
|
123 |
|
|
133 |
|
|
Accounts payable |
|
275 |
|
|
1,494 |
|
|
Accrued expenses and other current liabilities |
|
(3,411 |
) |
|
(2,571 |
) |
|
Operating lease liabilities |
|
(936 |
) |
|
(1,143 |
) |
|
Contract liabilities |
|
35 |
|
|
(969 |
) |
|
Other noncurrent liabilities |
|
(346 |
) |
|
— |
|
|
Net cash used in operating activities |
|
(21,814 |
) |
|
(41,508 |
) |
|
Cash flows from investing activities: | |||||||
Purchases of property and equipment |
|
(420 |
) |
|
(1,421 |
) |
|
Proceeds from sale of property and equipment |
|
45 |
|
|
243 |
|
|
Purchases of marketable securities |
|
(24,241 |
) |
|
(8,736 |
) |
|
Proceeds from redemptions and maturities of marketable securities |
|
27,756 |
|
|
76,350 |
|
|
Net cash provided by investing activities |
|
3,140 |
|
|
66,436 |
|
|
Cash flows from financing activities: | |||||||
Proceeds from exercise of stock options |
|
134 |
|
|
450 |
|
|
Proceeds from the issuance of convertible note |
|
146 |
|
|
— |
|
|
Payments for convertible note redemptions |
|
— |
|
|
(6,235 |
) |
|
Taxes paid related to the net share settlement of equity awards |
|
(113 |
) |
|
(1,312 |
) |
|
Proceeds from issuance of common stock under the Common Stock Purchase Agreements |
|
5,863 |
|
|
136 |
|
|
Stock issuance costs related to Common Stock Purchase Agreements |
|
(613 |
) |
|
— |
|
|
Proceeds from issuance of common stock through the Employee Stock Purchase Plan |
|
26 |
|
|
118 |
|
|
Net cash provided by (used in) financing activities |
|
5,443 |
|
|
(6,843 |
) |
|
Net (decrease) increase in cash, cash equivalents and restricted cash |
|
(13,231 |
) |
|
18,085 |
|
|
Cash, cash equivalents and restricted cash at beginning of period |
|
19,082 |
|
|
21,214 |
|
|
Cash, cash equivalents and restricted cash at end of period |
$ |
5,851 |
|
$ |
39,299 |
|
|
Reconciliation of GAAP to Non-GAAP Financial Measures (In thousands, except share amounts and per share data) (Unaudited) |
|||||||||||||||
Three months ended |
Nine months ended |
||||||||||||||
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
GAAP net loss |
$ |
(8,706 |
) |
$ |
(17,048 |
) |
$ |
(26,912 |
) |
$ |
(59,344 |
) |
|||
Non-GAAP adjustments: | |||||||||||||||
Stock-based compensation |
|
2,248 |
|
|
4,084 |
|
|
7,002 |
|
|
14,707 |
|
|||
Expenses related to registration statements and common stock purchase agreements |
|
1,136 |
|
|
233 |
|
|
1,136 |
|
|
233 |
|
|||
Change in fair value of convertible note and warrant liabilities |
|
(9 |
) |
|
(12 |
) |
|
4 |
|
|
914 |
|
|||
Realized loss on instrument-specific credit risk |
|
— |
|
|
46 |
|
|
— |
|
|
46 |
|
|||
One-time termination benefits and other restructuring costs |
|
— |
|
|
172 |
|
|
— |
|
|
1,470 |
|
|||
Non-routine write-down of inventory |
|
— |
|
|
3,007 |
|
|
— |
|
|
3,007 |
|
|||
Impairment of right-of-use assets |
|
— |
|
|
— |
|
|
— |
|
|
47 |
|
|||
Gain on termination of operating lease, net |
|
(680 |
) |
|
— |
|
|
(680 |
) |
|
— |
|
|||
Non-GAAP net loss |
$ |
(6,011 |
) |
$ |
(9,518 |
) |
$ |
(19,450 |
) |
$ |
(38,920 |
) |
|||
Depreciation and amortization expense |
|
24 |
|
|
332 |
|
|
80 |
|
|
998 |
|
|||
Interest income and other |
|
(233 |
) |
|
(354 |
) |
|
(656 |
) |
|
(932 |
) |
|||
Interest expense and other |
|
(34 |
) |
|
128 |
|
|
(407 |
) |
|
(84 |
) |
|||
Provision for income tax expense |
|
— |
|
|
5 |
|
|
2 |
|
|
43 |
|
|||
Adjusted EBITDA |
$ |
(6,254 |
) |
$ |
(9,407 |
) |
$ |
(20,431 |
) |
$ |
(38,895 |
) |
|||
GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted |
$ |
(1.01 |
) |
$ |
(2.78 |
) |
$ |
(3.90 |
) |
$ |
(10.34 |
) |
|||
Non-GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted |
$ |
(0.70 |
) |
$ |
(1.55 |
) |
$ |
(2.82 |
) |
$ |
(6.78 |
) |
|||
Shares used in computing GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted |
|
8,629,683 |
|
|
6,137,251 |
|
|
6,892,910 |
|
|
5,739,425 |
|
|||
Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted |
|
8,629,683 |
|
|
6,137,251 |
|
|
6,892,910 |
|
|
5,739,425 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20241112782801/en/
Investor Relations Contacts:
Agency Contact
eniu@finprofiles.com
310-622-8243
Company Contact
info@aeye.ai
925-400-4366
Source: